Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-05
DOI
10.1111/jdv.15045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
- (2018) T. Zuberbier et al. ALLERGY
- The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria
- (2018) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria
- (2018) Won-Sun Choi et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- The Urticaria Activity Score—Validity, Reliability, and Responsiveness
- (2018) Tomasz Hawro et al. Journal of Allergy and Clinical Immunology-In Practice
- Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria
- (2018) Matthew D. Straesser et al. Journal of Allergy and Clinical Immunology-In Practice
- Clinical Measures of Chronic Urticaria
- (2017) Karsten Weller et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Responsiveness and minimal important difference of the urticaria control test
- (2017) Tatevik Ohanyan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria
- (2017) Janine Gericke et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Increased IgE levels are linked to faster relapse in patients with omalizumab-discontinued chronic spontaneous urticaria
- (2017) Ragip Ertas et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Epidemiology and comorbidities of patients with chronic urticaria in Taiwan: A nationwide population-based study
- (2017) Chia-Yu Chu et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema
- (2017) M. Maurer et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria
- (2017) A.Y. Finlay et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Omalizumab for severe chronic spontaneous urticaria: Real-life experiences of 280 patients
- (2017) Zahava Vadasz et al. Journal of Allergy and Clinical Immunology-In Practice
- Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients
- (2016) M.N. Ghazanfar et al. BRITISH JOURNAL OF DERMATOLOGY
- Omalizumab for the treatment of chronic spontaneous urticaria: A meta-analysis of randomized clinical trials
- (2016) Zuo-Tao Zhao et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Lack of basophil CD203c-upregulating activity as an immunological marker to predict response to treatment with omalizumab in patients with symptomatic chronic urticaria
- (2016) Thamiris Palacios et al. Journal of Allergy and Clinical Immunology-In Practice
- Determining the Minimal Clinically Important Difference and Responsiveness of the Dermatology Life Quality Index (DLQI): Further Data
- (2015) M.K.A. Basra et al. DERMATOLOGY
- Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study
- (2015) Sarbjit S. Saini et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control
- (2014) Karsten Weller et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Retreatment With Omalizumab Results in Rapid Remission in Chronic Spontaneous and Inducible Urticaria
- (2014) Martin Metz et al. JAMA Dermatology
- Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy
- (2013) Allen Kaplan et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab for the Treatment of Chronic Idiopathic or Spontaneous Urticaria
- (2013) Marcus Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating the minimally important difference of the urticaria activity score and other measures of disease activity in patients with chronic idiopathic urticaria
- (2011) Susan D. Mathias et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase
- (2011) Marcus Maurer et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More